Experience with Reviewing Bayesian Medical Device Trials
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2007/12/10
-
Indian UGC (journal)
-
Refrences39
-
Citations58
-
Gene Pennello a Division of Biostatistics , Rockville, Maryland, USA
-
Laura Thompson a Division of Biostatistics , Rockville, Maryland, USA
Cite
Pennello, Gene, and Laura Thompson. “Experience With Reviewing Bayesian Medical Device Trials”. Journal of Biopharmaceutical Statistics, vol. 18, no. 1, 2007, pp. 81-115, https://doi.org/10.1080/10543400701668274.
Pennello, G., & Thompson, L. (2007). Experience with Reviewing Bayesian Medical Device Trials. Journal of Biopharmaceutical Statistics, 18(1), 81-115. https://doi.org/10.1080/10543400701668274
Pennello, Gene, and Laura Thompson. “Experience With Reviewing Bayesian Medical Device Trials”. Journal of Biopharmaceutical Statistics 18, no. 1 (2007): 81-115. https://doi.org/10.1080/10543400701668274.
Pennello G, Thompson L. Experience with Reviewing Bayesian Medical Device Trials. Journal of Biopharmaceutical Statistics. 2007;18(1):81-115.
Journal Categories
Medicine
Public aspects of medicine
Toxicology
Poisons
Medicine
Therapeutics
Pharmacology
Science
Mathematics
Probabilities
Mathematical statistics
You May Also Like
- Optimal caliper widths for propensity‐score matching when estimating differences in means and differences in proportions in observational studies
- Sample size of 12 per group rule of thumb for a pilot study
- Guidelines for accurate EC50/IC50 estimation
- Quantifying heterogeneity in a meta‐analysis
- Multiple imputation using chained equations: Issues and guidance for practice
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| 10.1081/BIP-120024200 | Journal of Biopharmaceutical Statistics |
| 2003 | |
| 10.1109/TMI.2002.1009380 | 2002 | |||
| 10.1016/S1076-6332(03)80372-0 | Academic Radiology |
| 2002 | |
| Interpretation of Subgroup Analyses in Medical Device Clinical Trials | Drug Information Journal | 5 | 1998 | |
| 10.1002/(SICI)1097-0258(19960830)15:16<1729::AID-SIM334>3.0.CO;2-M | Statistics in Medicine |
| 1996 |
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Beyond the classical type I error: Bayesian metrics for Bayesian designs using informative priors | Statistics in Biopharmaceutical Research |
| 2024 | |
Streamlining Randomized Clinical Trials for Device Therapies in Heart Failure: Bayesian Borrowing of External Data | Journal of the American Heart Association |
| 2024 | |
Utilization of treatment effect on a surrogate endpoint for planning a study to evaluate treatment effect on a final endpoint | Pharmaceutical Statistics |
| 2023 | |
| Bayesian Statistics for Medical Devices: Progress Since 2010 | Therapeutic Innovation & Regulatory Science |
| 1 | 2023 |
| Perspectives on informative Bayesian methods in pediatrics | Journal of Biopharmaceutical Statistics |
| 4 | 2023 |
Citations Analysis
The category
Science: Mathematics: Probabilities. Mathematical statistics 36
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Drug–diagnostic codevelopment strategies: FDA and industry dialog at the 4th FDA/DIA/PhRMA/PWG/BIO Pharmacogenomics Workshop and was published in 2009. The most recent citation comes from a 2024 study titled Beyond the classical type I error: Bayesian metrics for Bayesian designs using informative priors. This article reached its peak citation in 2020, with 8 citations. It has been cited in 28 different journals, 10% of which are open access. Among related journals, the Pharmaceutical Statistics cited this research the most, with 10 citations. The chart below illustrates the annual citation trends for this article.